Skip to main content
Cynthia Tifft, MD, Medical Genetics, Bethesda, MD

CynthiaJTifftMD

Medical Genetics • Bethesda, MD

Clinical Genetics

Physician

Join to view full profile

Dr. Tifft is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tifft's full profile

Already have an account?

  • Office

    10 Center Dr
    BETHESDA, MD
    Bethesda, MD 20892
    Phone+1 202-884-2187

Education & Training

  • National Capital Consortium
    National Capital ConsortiumResidency, Pediatrics, 1986 - 1987
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Pediatrics, 1984 - 1986
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1983

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1986 - 2025
  • DC State Medical License
    DC State Medical License 1991 - 2022
  • American Board of Medical Genetics and Genomics Clinical Genetics
  • American Board of Pediatrics Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease  
    Carlos A Bacino, Vandana Shashi, Euan A Ashley, Cynthia J Tifft, William A Gahl, Brendan H Lee, John J Mulvihill, Rizwan Hamid, Matthew T Wheeler, Jonathan A Bernstein..., The New England Journal of Medicine

Press Mentions

  • Sio Gene Therapies Announces CSF Reductions in GM1 Ganglioside from Clinical Trial of AXO-AAV-gm1 Gene Therapy
    Sio Gene Therapies Announces CSF Reductions in GM1 Ganglioside from Clinical Trial of AXO-AAV-gm1 Gene TherapyMay 13th, 2021
  • An Experimental Gene Therapy Was Little Alissa's Only Hope. Now, Instead of Certain Death, She Faces an Uncertain Future
    An Experimental Gene Therapy Was Little Alissa's Only Hope. Now, Instead of Certain Death, She Faces an Uncertain FutureApril 25th, 2021
  • Sio Gene Therapies Announces First Patient Dosed in High-Dose Cohort of AXO-AAV-gm1 Clinical Trial in Patients with GM1 Gangliosidosis
    Sio Gene Therapies Announces First Patient Dosed in High-Dose Cohort of AXO-AAV-gm1 Clinical Trial in Patients with GM1 GangliosidosisDecember 2nd, 2020
  • Join now to see all

Grant Support

  • An Exploratory, Open-Label Study Of The Safety AndNational Center For Research Resources2010
  • Pharmacokinetics, Safety, And Tolerability Of Zavesca (MIGLUSTAT) In PatientsNational Center For Research Resources2006–2008
  • Pathogenesis And Natural History Of The Glycosphingolipd (GSL) StorageNational Center For Research Resources2006

Dr. Cynthia Tifft, Dr. Cynthia Tifft, MD, Dr. C Tifft, Dr. Cynthia J Tifft